Population
Individuals at risk for atherosclerotic cardiovascular diseases (ASCVD) and dyslipidemia
Design
Guideline
Authors
Loading...
Apply 2017 JAS guidelines for ASCVD prevention; extends evidence-based lipid management for clinicians and researchers.
The 2017 Japan Atherosclerosis Society guidelines provide evidence-based recommendations for the prevention of ASCVD through lipid management, drug therapy, and lifestyle modifications.
Kinoshita et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: